title: [Residual liver cancer after transcatheter hepatic arterial chemoembolization in patients with large primary hepatic carcinoma].
abstract: 15 cancer specimens resected after hepatic arterial chemoembolization (TCE) were studied pathologically. It was found that residual tumor tissue was present in three forms: failure of complete tumor necrosis; tumor emboli in small portal veins; and multiple cancer foci in adjacent liver parenchyma. It is believed that presenting residual tumor tissue after TCE may be attributed to one of the following conditions: low drug concentration in residual tumor tissue; the larger tumor size after TCE; more residual cancer tissue in ASCCL than in HCC, collaterals formed soon after hepatic arterial occlusion.
authors.affiliation: Jiangxi Medical College, Nanchang.
authors.forename: Y S
authors.initials: YS
authors.lastname: Tan
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000473:pathology* / Q000628:therapy; D016461:Chemoembolization, Therapeutic; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007459:Iodized Oil / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000473:pathology* / Q000628:therapy; D008937:Mitomycins / Q000008:administration & dosage
chemical_list: D008937:Mitomycins; D007459:Iodized Oil; D004317:Doxorubicin